Virtual Medicinal Product (VMP) - Reteplase 10unit powder and solvent for solution for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Reteplase 10unit powder and solvent for solution for injection vials Start Date 09-06-2004 End Date
Previous Name Previous Name Reteplase 10unit injection vials and diluent Start Date 12-08-2003 End Date 08-06-2004
Abbreviated Name Abbreviated Name Reteplase 10unit inj vials Start Date 01-05-2009
Previous Abbreviated Name Reteplase 10unit pdr & solv for soln for inj vials Previous Start Date 14-09-2004 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Powder and solvent for solution for injection
Ontology Form/Route
solutioninjection.intravenous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
B01AD07
BNF Start Date End Date
Current BNF 02100200 Start Date 04-04-2022 End Date
Previous BNF 02100200 Start Date 11-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
35934211000001100 22-10-2018
319845001 12-08-2003 21-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Reteplase Based on Ingredient Substance 10 unit

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
2 vial